Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.
Saved in:
| Title: | Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study. |
|---|---|
| Authors: | Sundy JS (AUTHOR), Becker MA (AUTHOR), Baraf HSB (AUTHOR), Barkhuizen A (AUTHOR), Moreland LW (AUTHOR), Huang W (AUTHOR), Waltrip RW II (AUTHOR), Maroli AN (AUTHOR), Horowitz Z (AUTHOR), Pegloticase Phase 2 Study Investigators (CORPORATE AUTHOR) |
| Source: | Arthritis & Rheumatism. Sep2008, Vol. 58 Issue 9, p2882-2891. 10p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 105671917 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Sundy+JS%22">Sundy JS</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Becker+MA%22">Becker MA</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baraf+HSB%22">Baraf HSB</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Barkhuizen+A%22">Barkhuizen A</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moreland+LW%22">Moreland LW</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang+W%22">Huang W</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Waltrip+RW+II%22">Waltrip RW II</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maroli+AN%22">Maroli AN</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Horowitz+Z%22">Horowitz Z</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pegloticase+Phase+2+Study+Investigators%22">Pegloticase Phase 2 Study Investigators</searchLink> (CORPORATE AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Arthritis+%26+Rheumatism%22">Arthritis & Rheumatism</searchLink>. Sep2008, Vol. 58 Issue 9, p2882-2891. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=105671917 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/art.23810 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 2882 Titles: – TitleFull: Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sundy JS – PersonEntity: Name: NameFull: Becker MA – PersonEntity: Name: NameFull: Baraf HSB – PersonEntity: Name: NameFull: Barkhuizen A – PersonEntity: Name: NameFull: Moreland LW – PersonEntity: Name: NameFull: Huang W – PersonEntity: Name: NameFull: Waltrip RW II – PersonEntity: Name: NameFull: Maroli AN – PersonEntity: Name: NameFull: Horowitz Z – PersonEntity: Name: NameFull: Pegloticase Phase 2 Study Investigators IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: Sep2008 Type: published Y: 2008 Identifiers: – Type: issn-print Value: 00043591 Numbering: – Type: volume Value: 58 – Type: issue Value: 9 Titles: – TitleFull: Arthritis & Rheumatism Type: main |
| ResultId | 1 |
